Anti-CD55 x Anti-HLA-A Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD55 and anti-HLA-A parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY